Abstract-We report here the synthesis of a series of mono-to trivalent N-acetylglucosamine (GlcNAc) derivatives as ligands for the plant lectin wheat germ agglutinin (WGA). Their WGA binding potencies were determined by an established enzyme-linked lectin assay (ELLA) employing microtiter plates with non-covalently immobilized porcine stomach mucin (PSM) as reference ligand and an ELLA with a new GlcNAc derivative covalently immobilized via a thiourea linkage. Comparison of both assays revealed that the type of presentation of GlcNAc residues on the microtiter plates either as part of a glycoprotein or as a covalently immobilized monosaccharide derivative strongly influences the outcome of the assay. Although the apparent dissociation constants K ELLA D for the interaction of peroxidase-labeled WGA with the microtiter plates are comparable for both surfaces, IC 50 values obtained with the PSM-free ELLA were substantially lower. Even more strikingly, this ELLA displayed a better differentiation between ligands of different valency leading to significantly higher relative inhibitory potencies of multivalent ligands compared to monovalent. Additionally, problems associated with the use of PSM, such as maximum inhibition at considerably less than 100% and poor reproducibility of IC 50 values could be overcome with this type of ELLA.
Introduction
The specific recognition of carbohydrate structures in biological systems by carbohydrate-binding proteins (lectins) [1] [2] [3] [4] is the basis of numerous intra-and intercellular events ranging from the control of protein folding to cell-cell communication during development, inflammation, immune responses, and cancer metastasis. [5] [6] [7] [8] [9] High affinity lectin ligands are of great medicinal interest in the diagnosis and inhibition of such carbohydrate-mediated processes. [10] [11] [12] [13] [14] [15] The generation of high affinity ligands, however, is not trivial because the interaction of individual carbohydrate epitopes with lectins is in many cases weak and undiscriminating. 16 The binding affinity can be dramatically increased by clustering of lectin binding sites and carbohydrate recognition units. [17] [18] [19] [20] [21] [22] [23] The observation that the binding affinity increases exponentially with the number of binding sites has been termed the glycoside cluster effect. 24, 25 The potency of a polyvalent inhibitor depends on the spatial presentation of the carbohydrates and the associated possibility of occupying several binding sites simultaneously 26 and is often assessed in terms of a relative inhibitory potency compared to the monovalent interaction. If the 3D structure of a lectin is known, suitable multivalent ligands may be obtained by rational design. 27, 28 However, if the three-dimensional orientation of the binding sites of a lectin is not known, many potential ligands have to be synthesized and screened to determine the required orientation of the carbohydrate units.
Enzyme-linked lectin assays (ELLA) 29 provide a fast method to evaluate lectin binding properties of soluble natural or synthetic lectin ligands in solution. [30] [31] [32] [33] [34] Microtiter plates are coated with a reference ligand (often a (neo)glycoprotein or polysaccharide) and IC 50 values for inhibition of the binding of an enzyme-labeled lectin to the immobilized reference ligand (the matrix) by the soluble ligands to be tested are determined. The advantage of ELLA compared to solid-phase binding assays such as surface plasmon resonance (SPR) 35 is that both, lectin and ligand are in solution. However, the use of glycoproteins from natural sources as reference ligands is limited because their varying complex
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carbohydrate composition due to microheterogeneity 36 leads to reduced reproducibility of IC 50 values. Furthermore, incomplete inhibition of lectin binding to the plate surface is often observed, that is, maximal inhibition occurs at considerably less than 100%. To overcome the problem of microheterogeneity, covalent immobilization of defined synthetic carbohydrates and their application in an enzyme-linked immunosorbent assay (ELISA) employing PapG adhesin was reported. 37 From screening of a 19440-membered split-and-mix library of conformationally restricted spatially diverse glycoclusters, we were able to identify a number of tetrato hexavalent ligands of the plant lectin wheat germ agglutinin (WGA) with affinities up to 620-fold compared to the binding of the monovalent ligand N-acetylglucosamine (GlcNAc). 38 WGA is a 36-kDa lectin composed of two identical glycine-and cysteine-rich subunits. 39 The WGA dimer contains a total of eight binding sites for GlcNAc and oligomers thereof. 40 The results demonstrated that the binding affinity of the identified ligands was not only determined by the number of GlcNAc residues but that ligand architecture is important as well.
Here we present a series of structurally diverse mono-to trivalent GlcNAc derivatives which were synthesized to explore the effects of scaffold structure on the binding affinity toward WGA. IC 50 values were determined by a published ELLA 38, 41 and an ELLA employing a newly developed GlcNAc derivative which was covalently immobilized to microtiter plates via a thiourea linkage leading to improved properties regarding sensitivity and reproducibility. Comparison of both assays revealed interesting insight into the influence of the type of carbohydrate presentation on the microtiter plates on the results of the assay.
Results and discussion

Synthesis of WGA ligands
In a previous study we identified several cyclic neoglycopeptides containing four to six GlcNAc residues as ligands for WGA. 38 Interestingly, a pentavalent compound showed a lower IC 50 value than a hexavalent, as determined by an ELLA. This indicated that the binding affinity is not only determined by the number of GlcNAc residues but that their spatial presentation is important as well. In order to further investigate the effects of the structure of multivalent GlcNAc derivatives on the binding affinity toward WGA, a series of compounds were prepared. Commercially available amines 1-8 ( Fig. 1) were reacted with activated carbonate 9, which was already used for the preparation of neoglycopeptides, 42 leading to mono-to trivalent glycoconjugates 10-17 in high yields (Table 1) . Subsequent Odeacetylation resulted in WGA ligands 18-25 in quantitative yields (Scheme 1). When reacted under Zemplén conditions followed by neutralization using acidic ion exchange resin, some of the products (especially the amines 24 and 25) adhered to the resin. Therefore, O-deacetylation was conveniently carried out under salt free conditions using N-ethyldimethylamine in methanol.
In addition, hydroxybutenyl glycoside 27, obtained by O-deacetylation of compound 26, 43 GlcNAc 28, and allyl 2-acetamido-2-deoxy-b-D D-glucopyranoside 29 were used as monovalent WGA ligands (Scheme 2).
ELLA employing non-covalently immobilized porcine stomach mucin as reference ligand
Binding potencies of compounds 18-25 and 27-29 were determined by an ELLA employing non-covalently immobilized porcine stomach mucin (PSM) as reference ligand as described earlier. 38 under the given experimental conditions was not observed. After incubation, the plates were washed and remaining labeled WGA bound to the reference ligand was quantified by a HRP-catalyzed color reaction using 2,2 0 -azinobis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) as substrate. Dose-response curves for inhibition of the binding of HRP-labeled WGA to immobilized PSM are shown in Figure 2 . From these curves the concentrations that reduce the binding of labeled WGA to PSM by 50% (IC 50 values) were determined as a measure of potency of the synthesized inhibitors (Table 2 , column A). Also shown in Table 2 are relative inhibitory potencies (b values) referenced to GlcNAc 28 (b = 1).
As shown in Table 2 , column A, the IC 50 value of GlcNAc 28 was determined to be 1000 mM. In order to validate the assay, we determined the inhibitory potency of allyl 2-acetamido-2-deoxy-a-D D-glucopyranoside at a concentration of 15 mM to be 12% (data not shown). This corresponds well to the value of 15% published by Zanini that they are exceptionally steep. One possible explanation for this behavior is increasing aggregation of the ligands at higher concentrations, leading to higher valency and, therefore, better inhibition. In this regard, it is conspicuous that the inhibition curve of monovalent derivative 19 containing benzyl groups also displays this behavior.
As shown in Figure 2, For the synthesis of 33, activated carbonate 9 was reacted with mono tritylated diamine 35 to give urethane 36 in quantitative yield (Scheme 4). Detritylation using trifluoroacetic acid (TFA) and triisopropyl silane (TIS) and subsequent O-deacetylation of 37 yielded 33.
To determine the performance of the surfaces 31 and 34, microtiter plates prepared under various conditions were blocked with bovine serum albumin (BSA) and incubated with a series of differently concentrated WGA-HRP solutions. After washing, HRP substrate ABTS was added and the absorption was measured at 405 nm (Fig. 3 ). This allowed quantification of HRP-labeled lectin bound to the plates. To generate surface 31, the concentration of activated carbonate 9 was varied between 0.06 and 100 mM. Incubation with WGA-HRP occurred at concentrations between 0.2 and 25 lg mL À1 . As shown in Figure 3a , the amount of bound WGA-HRP is very low (A 405 generally below 0.5) and does not correlate with the concentration of activated carbonate 9 used for surface preparation.
From these results we conclude that the observed binding of WGA-HRP is not a matter of a specific interaction with the immobilized GlcNAc residues. This may originate from the short distance between the plate surface and the GlcNAc residues reducing the accessibility of the GlcNAc residues to the WGA binding sites.
51
A completely different behavior was observed with longspacer surface 34. A clear relationship between the concentration of 33 used for derivatization of 32 and the amount of WGA-HRP bound to the surface is observed (Fig. 3b ). At concentrations of amine 33 P1 mM, the reactive surface of the plate is saturated and binding curves consistent with simple ligand binding are obtained with increasing WGA-HRP concentration. Additionally, the total amount of WGA-HRP bound to surface 34 is much higher compared to 31. Therefore, all following experiments were carried out with microtiter plates 34 obtained by treatment of 32 with 1 mM solutions of GlcNAc derivative 33.
Determination of inhibitory potencies.
Inhibition experiments with ligands 27-29, 20, 23, and 25 were carried out as described above for PSM-coated microtiter plates at WGA-HRP concentrations of 1 lg mL À1 . Dose-response curves for inhibition of the binding of HRP-labeled WGA to covalently immobilized GlcNAc 34 are shown in Figure 4 . IC 50 values obtained from these curves are given in Table 2 , column B.
As can be seen immediately, IC 50 Figure 2b , it is obviously not any more effective at the low concentration needed for inhibition of WGA binding to the covalently modified plates. Additionally, due to the lower IC 50 values observed with this variant of the ELLA, limited solubility did not any more prevent reaching maximal inhibition with all tested ligands.
It is well known that the performance of multivalent carbohydrate ligands is strongly dependent on the assay used to evaluate them because different phenomena may be measured. This does not only apply to absolute IC 50 values but also to observed multivalency effects, that is, relative IC 50 values. Toone et al., for example, compared a range of competitive and non-competitive binding assays, including ELLA, hemagglutination inhibition, and isothermal titration microcalorimetry 32 and Pieters et al. studied multivalent galectin ligands by a solid-phase inhibition assay and fluorescence titrations in solution. 52 There are also few reports that show that the use of ELLA with different matrices can lead to different relative inhibitory potencies. 33, 53 This phenomenon, however, is not well understood.
A likely explanation for different absolute IC 50 for the interaction of WGA-HRP with surface 34, which corresponds to the concentration of WGA-HRP necessary to occupy 50% of the surface binding sites, was readily available from the binding curves shown in Figure 3b . Data for the PSMcoated surface were obtained from an analogous experiment. As shown in the semi-logarithmic plot in Figure  5 , K 50 values with surface 34. A closer examination of the binding curves reveals two differences. Whereas the binding curve for covalently modified plates 34 perfectly fits to a Langmuir isotherm (Hill coefficient = 1), the binding curve for PSM-coated plates is much steeper with a Hill coefficient of 2. At the same time, PSM-coated plates were estimated to bind roughly twice the amount of WGA-HRP per unit surface area compared with surface 34. These results underline the importance of the topology of carbohydrate presentation on surfaces, such as cell membranes or carbohydrate microarrays, for the affinity and specificity of carbohydrate-lectin interactions. At this point, it is worth mentioning that the IC 50 value of GlcNAc determined by the new assay (23 mM) is in much closer proximity to the K D value of GlcNAc which has been determined by several groups employing different methods [54] [55] [56] [57] [58] to be in the range of approximately 1-5 mM.
As mentioned in the introduction, a disadvantage of ELLA is that in many cases maximal inhibition occurs at considerably less than 100%. When we, for example, determined the IC 50 values of cyclic neoglycopeptides, such as 38, for inhibition of WGA-HRP binding to PSM-coated microtiter plates, a maximum inhibition of approximately 70% was observed. 38 The reasons for this behavior are obscure but might be rooted in the presence of several different binding sites on PSM which is a highly glycosylated glycoprotein existing in many glycoforms. It is known that WGA also binds to N-acetylneuraminic acid 39 and it may be that this interaction is not inhibited by GlcNAc derivatives. Therefore, we subjected 38 to the ELLA with covalently immobilized GlcNAc. As can be seen in Figure 4 , the maximal inhibition of WGA-HRP binding to this surface presenting a homogeneous carbohydrate epitope is now close to 100%. The IC 50 value of 38 is 16 lM corresponding to a b of 1440 ( Table 2 ). The previously determined IC 50 employing PSM-coated microtiter plates was 0.38 mM (b = 218). 
Conclusions
In for the interaction of WGA-HRP with the microtiter plates are comparable for both surfaces, IC 50 values obtained with the PSM-free ELLA were substantially lower. Furthermore, this ELLA displays a better differentiation between ligands of different valency leading to significantly higher relative inhibitory potencies (b values) of multivalent ligands. Covalent immobilization of carbohydrate derivative 33 allows for generation of a chemically defined carbohydrate presentation. Problems associated with the use of PSM, such as maximum inhibition at considerably less than 100%, poor reproducibility of IC 50 values, and insufficient solubility of the inhibitors at the concentrations required for maximum inhibition, could be overcome with this ELLA.
Experimental
General methods
Solvents were purified by distillation and dried by normal procedures. Thin-layer chromatography (TLC) was performed on Merck silica gel 60 F 254 aluminum sheets. The sheets were visualized by UV light and immersion in the appropriate stain followed by heating.
Preparative flash column chromatography (FC) was carried out on Merck silica gel 60 (40-63 lm).
1 H NMR and 13 C NMR spectra were recorded on Bruker AC 250, Bruker AMX 400, and Bruker Avance DRX 600 instruments. (1.1 equiv per amino group) is dissolved in dry CH 2 Cl 2 (3-11 mL per mmol 9). Addition of the amine and EtN(i-Pr) 2 (1 equiv base per amino group) affords a yellow colored solution. The reaction mixture is stirred at room temperature until the reaction is complete. After evaporation of the solvent, the residue is purified by FC. 
General procedure 2 (GP
4-(2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D Dglucopyranosyloxy)-(Z)-but-2-enyloxycarbonyl-propylamine (10).
According to GP 1, 9 (320 mg, 0.55 mmol), CH 2 Cl 2 (5 mL), propylamine (41 lL, 0.5 mmol), and EtN(i-Pr) 2 
4-(2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D D-glucopyranosyloxy)-(Z)-but-2-enyloxycarbonyl-benzyl-amine (11).
According to GP 1, 9 (291 mg, 0.5 mmol), CH 2 Cl 2 (1.5 mL), benzylamine (60 lL, 0.55 mmol), and EtN(iPr) 2 (87 lL, 0.5 mmol) were reacted overnight. FC (EtOAc) gave 11 (258 mg, 94%) as a slight brown solid. 50, 60 containing 0.4% EtN(i-Pr) 2 for 3 h at room temperature (100 lL per well). Then the plates were emptied and rinsed twice with isopropanol, twice with water, and twice with sodium carbonate/ bicarbonate buffer (100 mM, pH 10.1) to give modified microtiter plates (32).
4.3.4.
Protocol for covalent immobilization of compound 33 to the modified microtiter plates (32) . The modified microtiter plates 32 were incubated with a 1 mM solution of compound 33 in sodium carbonate/bicarbonate buffer (100 mM, pH 10.1) overnight at room temperature (100 lL per well). The wells were then washed once with isopropanol and twice with PBST buffer (pH 7.3) to give microtiter plates 34. 4.3.5. Protocol for the ELLA employing covalently modified microtiter plates (34) . This assay was carried out as described above for microtiter plates with noncovalently immobilized porcine stomach mucin except that 100 lL per well of each ABTS solution and H 2 SO 4 were used. All tests were performed in duplicate.
